Previous | Next
680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731731a of 999
anybody can -- she's got persistence and energy, and she'll
That's great. Can I ask you to talk about, what are there?
Four meetings a year of the Cancer Advisory Board?
Yes, four meetings a year. Various subjects are
brought up before them. That's a very disparate group of
men and only two women, and very few of them are very hot about
clinical advances. A lot of them are basic researchers or
surgeons who don't have much hope or much vision of clinical
advances, so that it's very frustrating to be at the meetings
most of the time. They do have reports of what's going on,
and sometimes the reports are quite good and interesting,
but I don't feel that these are major -- very seldom are
them major new thrusts discussed or implemented.
Now, maybe one day we'll do something about interferon
or some other drugs. That will be a decision taken to do
something new and crucial, but a great deal of effort is being
supported notwithstanding all the indifference to the patients.
But a lot of the decisions are not made on that
board. That's just an advisory board, and it's usually done
by the staff and the Director of the Cancer Institute. I don't
feel that one gets a great deal done in the meetings. At least,
I don't, I don't think.
Tell me also, the subject of the awards for the Lasker
For this year? One is going to be to the people that
discovered enkephalins and endorphins. The other is going to
© 2006 Columbia University
Libraries | Oral History
Research Office | Rights and
Permissions | Help